- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic evaluation of piperacillin-tazobactam
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 6, Issue 8, Pages 1017-1031
Publisher
Informa Healthcare
Online
2010-07-19
DOI
10.1517/17425255.2010.506187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Francis Tally and the Discovery and Development of Tigecycline: A Personal Reminiscence
- (2010) Steven J. Projan CLINICAL INFECTIOUS DISEASES
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Daily serum piperacillin monitoring is advisable in critically ill patients
- (2010) Nicolas Blondiaux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003–2008
- (2010) Hui Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)
- (2010) David J. Farrell et al. JOURNAL OF INFECTION
- In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST)
- (2010) Elisabeth Nagy et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Inhibitor Resistance in the KPC-2 -Lactamase, a Preeminent Property of This Class A -Lactamase
- (2009) K. M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rates of antimicrobial resistance in latin america (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics
- (2009) Flávia Rossi et al. Brazilian Journal of Infectious Diseases
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America
- (2009) Leonard A. Mermel et al. CLINICAL INFECTIOUS DISEASES
- Diagnosis and Management of Complicated Intra‐abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
- (2009) Joseph S. Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia*
- (2009) Emmanuel Boselli et al. CRITICAL CARE MEDICINE
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
- (2009) R Phillip Dellinger et al. CRITICAL CARE MEDICINE
- Pharmacokinetic issues for antibiotics in the critically ill patient
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Piperacillin penetration into tissue of critically ill patients with sepsis—Bolus versus continuous administration?
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997–2007)
- (2009) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004 to 2007
- (2009) Mark W. Garrison et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents
- (2009) Takaji Fujimura et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients
- (2009) Katherine M. Shea et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
- (2009) Jason A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United States
- (2008) C. M. Pillar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study
- (2008) Álvaro Réa-Neto et al. CURRENT MEDICAL RESEARCH AND OPINION
- Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006
- (2008) George G. Zhanel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates
- (2008) Philip J. Turner DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started